Works matching AU Park, Julie


Results: 206
    1
    2
    3
    4
    5
    6
    7
    8
    9

    A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies.

    Published in:
    Pediatric Hematology & Oncology, 2020, v. 37, n. 6, p. 465, doi. 10.1080/08880018.2020.1752869
    By:
    • Goldberg, John;
    • Sulis, Maria Luisa;
    • Bender, Julia;
    • Jeha, Sima;
    • Gardner, Rebecca;
    • Pollard, Jessica;
    • Aquino, Victor;
    • Laetsch, Theodore;
    • Winick, Naomi;
    • Fu, Cecilia;
    • Marcus, Leigh;
    • Sun, Weili;
    • Verma, Anupam;
    • Burke, Michael;
    • Ho, Phoenix;
    • Manley, Thomas;
    • Mody, Rajen;
    • Tcheng, Wendy;
    • Thomson, Blythe;
    • Park, Julie
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Book reviews.

    Published in:
    1994
    By:
    • Park, Julie
    Publication type:
    Book Review
    33
    34
    35
    36
    37
    38

    Real‐world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR‐2 retrospective chart review study.

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 4, p. 749, doi. 10.1111/bjh.18519
    By:
    • Hess, Georg;
    • Dreyling, Martin;
    • Oberic, Lucie;
    • Gine, Eva;
    • Zinzani, Pier Luigi;
    • Linton, Kim;
    • Vilmar, Adam;
    • Jerkeman, Mats;
    • Chen, Jenny M. H.;
    • Ohler, Anke;
    • Stilgenbauer, Stephan;
    • Thieblemont, Catherine;
    • Lambert, Jonathan;
    • Zilioli, Vittorio Ruggero;
    • Sancho, Juan‐Manuel;
    • Jiménez‐Ubieto, Ana;
    • Fischer, Luca;
    • Eyre, Toby A.;
    • Keeping, Sam;
    • Park, Julie E.
    Publication type:
    Article
    39

    Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.

    Published in:
    2019
    By:
    • Braunstein, Steve E.;
    • London, Wendy B.;
    • Kreissman, Susan G.;
    • Villablanca, Judith G.;
    • Davidoff, Andrew M.;
    • DeSantes, Kenneth;
    • Castleberry, Robert P.;
    • Murray, Kevin;
    • Diller, Lisa;
    • Matthay, Katherine;
    • Cohn, Susan L.;
    • Shulkin, Barry;
    • Allmen, Daniel;
    • Parisi, Marguerite T.;
    • Ryn, Collin;
    • Park, Julie R.;
    • Quaglia, Michael P.;
    • Haas‐Kogan, Daphne A.;
    • von Allmen, Daniel;
    • Van Ryn, Collin
    Publication type:
    journal article
    40

    The challenge of defining "ultra-high-risk" neuroblastoma.

    Published in:
    2019
    By:
    • Morgenstern, Daniel A.;
    • Bagatell, Rochelle;
    • Cohn, Susan L.;
    • Hogarty, Michael D.;
    • Maris, John M.;
    • Moreno, Lucas;
    • Park, Julie R.;
    • Pearson, Andrew D.;
    • Schleiermacher, Gudrun;
    • Valteau‐Couanet, Dominique;
    • London, Wendy B.;
    • Irwin, Meredith S.;
    • Valteau-Couanet, Dominique
    Publication type:
    journal article
    41
    42

    Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

    Published in:
    2018
    By:
    • Pinto, Navin;
    • DuBois, Steven G.;
    • Marachelian, Araz;
    • Diede, Scott J.;
    • Taraseviciute, Agne;
    • Glade Bender, Julia L.;
    • Tsao‐Wei, Denice;
    • Groshen, Susan G.;
    • Reid, Joel M.;
    • Haas‐Kogan, Daphne A.;
    • Reynolds, C. Patrick;
    • Kang, Min H.;
    • Irwin, Meredith S.;
    • Macy, Margaret E.;
    • Villablanca, Judith G.;
    • Matthay, Katherine K.;
    • Park, Julie R.;
    • Tsao-Wei, Denice;
    • Haas-Kogan, Daphne A
    Publication type:
    journal article
    43
    44
    45
    46
    47
    48
    49
    50